Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events

NCT00345839 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00345839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00345839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
August 22, 2006
Completion date
April 10, 2012
Enrollment
3,883 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, secondary hyperparathyroidism